Long-term follow-up after tight control of blood pressure in type 2 diabetes

Cited by (761)

Items 101–200 of 761

1. Premature cardiovascular events and mortality in south Asians with type 2 diabetes in the United Kingdom Asian Diabetes Study – effect of ethnicity on risk
   Srikanth Bellary, JAMES P. OʼHARE, Neil T. Raymond, Shanaz Mughal, Wasim Hanif, Alan F. Jones, Sudhesh Kumar, Anthony H Barnett · 2010 · Current Medical Research and Opinion
2. Screening for Prediabetes and Type 2 Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
   Jonas, Daniel E., Crotty, Karen, Yun, Jonathan D. Y., Middleton, Jennifer Cook, Feltner, Cynthia, Taylor-Phillips, Sian, Barclay, Colleen, Dotson, Andrea, Baker, Claire, Balio, Casey P. et al. · 2021 · JAMA
3. Cerebrovascular complications of diabetes: focus on cognitive dysfunction
   Trevor Hardigan, Rebecca Ward, Adviye Ergul · 2016 · Clinical Science
4. Blood Pressure and Cardiovascular Disease Risk in the Veterans Affairs Diabetes Trial
   Anderson, Robert J., Bahn, Gideon D., Moritz, Thomas E., Kaufman, Derrick, Abraira, Carlos, Duckworth, William, for the VADT Study Group · 2011 · Diabetes Care
5. Physical activity and dietary interventions in diabetic neuropathy: a systematic review
   Lindsay A. Zilliox, James W. Russell · 2019 · Clinical Autonomic Research
6. Chronic kidney disease and diabetes in the National Health Service: a cross‐sectional survey of the UK National Diabetes Audit
   Christopher J. Hill, Chris R. Cardwell, Chris C. Patterson, Alexander Peter Maxwell, G. M. Magee, Robert J. Young, Beverley B. Matthews, Donal J. O'Donoghue, Damian G. Fogarty · 2013 · Diabetic Medicine
7. Medical Care and Payment for Diabetes in China: Enormous Threat and Great Opportunity
   Wenying Yang, Wenhui Zhao, Jianzhong Xiao, Rui Li, Ping Zhang, Katarzyna Kissimova‐Skarbek, Erin Schneider, Weiping Jia, Linong Ji, Xiaohui Guo et al. · 2012 · PLoS ONE
8. A call to incorporate the prevention and treatment of geriatric disorders in the management of diabetes in the elderly
   Ulrich M. Vischer, Bernard Bauduceau, Isabelle Bourdel‐Marchasson, J F Blicklé, Thierry Constans, Anne Fagot‐Campagna, Edgar Kaloustian, V. Lassman-Vague, P. Lecomte, D. Simon et al. · 2009 · Diabetes & Metabolism
9. Catalase overexpression prevents hypertension and tubular apoptosis in angiotensinogen transgenic mice
   Nicolas Godin, Fang Liu, Garnet Lau, Marie-Luise Brezniceanu, Isabelle Chénier, János G. Filep, Julie R. Ingelfinger, Shao‐Ling Zhang, John S.D. Chan · 2010 · Kidney International
10. Pharmacologic Prevention of Microvascular and Macrovascular Complications in Diabetes Mellitus
    Nikhil Tandon, Mohammed Kumail Ali, K.M. Venkat Narayan · 2012 · American Journal of Cardiovascular Drugs
11. Consumption of sucrose and high-fructose corn syrup does not increase liver fat or ectopic fat deposition in muscles
    Bravo, Stephen, Lowndes, Joshua, Sinnett, Stephanie, Yu, Zhiping, Rippe, James · 2013 · Applied Physiology, Nutrition, and Metabolism
12. Beta-blockers in hypertension: overview and meta-analysis of randomized outcome trials
    Costas Thomopoulos, George Bazoukis, Costas P. Tsioufis, Giuseppe Mancia · 2020 · Journal of Hypertension
13. Prognostic significance of hemoglobin A1c level in patients hospitalized with coronary artery disease. A systematic review and meta-analysis
    Yao Z. Liu, Yanmin Yang, Jun Zhu, Huiqiong Tan, Yan Liang, Jiandong Li · 2011 · Cardiovascular Diabetology
14. The ADDITION-Cambridge trial protocol: a cluster – randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients
    Justin Basile Echouffo-Tcheugui, Rebecca K. Simmons, Kate M Williams, R. S. Barling, Andrew Toby Prevost, Ann Louise Kinmonth, Nicholas J. Wareham, Simon J. Griffin · 2009 · BMC Public Health
15. Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity
    Gallwitz, Baptist · 2022 · Frontiers in Endocrinology
16. Quality of Diabetes Care at a Student-Run Free Clinic
    Kira L. Ryskina, Yasmin S. Meah, David C. Thomas · 2009 · Journal of Health Care for the Poor and Underserved
17. Characteristics of Peripheral Arterial Disease and Its Relevance to the Diabetic Population
    Ezio Faglia · 2011 · The International Journal of Lower Extremity Wounds
18. Blood pressure control for diabetic retinopathy
    V. Diana, Genie Han, Samuel A. Abariga, Gina G. Sleilati, S. Swaroop Vedula, Barbara S. Hawkins · 2023 · Cochrane Database of Systematic Reviews
19. Legacy Effects from DCCT and UKPDS: What They Mean and Implications for Future Diabetes Trials
    Patrick T. Murray, G. Chune, Vasudevan A. Raghavan · 2010 · Current Atherosclerosis Reports
20. Association of Treatment With Metformin vs Sulfonylurea With Major Adverse Cardiovascular Events Among Patients With Diabetes and Reduced Kidney Function
    Christianne L. Roumie, Jonathan Chipman, Jea Young Min, Amber J. Hackstadt, Adriana M. Hung, Robert A. Greevy, Carlos G. Grijalva, Tom A. Elasy, Marie R. Griffin · 2019 · JAMA
21. Renal Function in Type 2 Diabetes with Rosiglitazone, Metformin, and Glyburide Monotherapy
    John M. Lachin, Giancarlo C. Viberti, Bernard Zinman, Steven M. Haffner, R. Paul Aftring, Gitanjali Paul, Barbara G. Kravitz, William H. Herman, Rury R. Holman, Steven E. Kahn · 2011 · Clinical Journal of the American Society of Nephrology
22. Socioeconomic Factors in the Development of Childhood Obesity and Diabetes
    David C. Lieb, Rodney E. Snow, Mark Daniel DeBoer · 2009 · Clinics in Sports Medicine
23. Peripheral Arterial Disease
    Janice V. Mascarenhas, Mostafa A. Albayati, Clifford P. Shearman, Edward Bernard Jude · 2014 · Endocrinology and Metabolism Clinics of North America
24. Proteinuria in Diabetes
    Janaka J. Karalliedde, Giancarlo C. Viberti · 2010 · Journal of the American Society of Nephrology
25. Anti-diabetic effects of Bifidobacterium animalis 01 through improving hepatic insulin sensitivity in type 2 diabetic rat model
    Jinlan Zhang, Shibo Wang, Zhu Zeng, Yuxuan Qin, Qian Shen, Pinglan Li · 2020 · Journal of Functional Foods
26. Cellular and molecular mechanisms of diabetic glomerulopathy
    Luigi Gnudi · 2012 · Nephrology Dialysis Transplantation
27. Diabetes and cardiovascular disease: pathophysiology of a life-threatening epidemic
    Rhodri King, Peter J. Grant · 2016 · Herz
28. Current role of beta-blockers in the treatment of hypertension
    Wilbert S. Aronow · 2010 · Expert Opinion on Pharmacotherapy
29. The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology
    Wendy C. Burns, Merlin C. Thomas · 2010 · Expert Reviews in Molecular Medicine
30. Fifty Years of Thiazide Diuretic Therapy for Hypertension
    Marvin Moser · 2009 · Archives of Internal Medicine
31. Triglyceride–glucose index is a predictor of incident chronic kidney disease: a population-based longitudinal study
    Takuro Okamura, Yoshitaka Hashimoto, Masahide Hamaguchi, Akihiro Obora, Takao Kojima, Michiaki Fukui · 2019 · Clinical and Experimental Nephrology
32. The impact of cardiovascular co-morbidities and duration of diabetes on the association between microvascular function and glycaemic control
    Francesco Casanova, Damilola D. Adingupu, F. Adams, Kim M. Gooding, Helen C. Looker, Kunihiko Aizawa, Fiona Dove, Salim Elyas, J. J. F. Belch, Phillip E. Gates et al. · 2017 · Cardiovascular Diabetology
33. Management of Cardiovascular Disease Risk Factors in Older Adults with Type 2 Diabetes Mellitus: 2002–2012 Literature Review
    Gerardo Moreno, Carol M. Mangione · 2013 · Journal of the American Geriatrics Society
34. Risk factors for ischemic stroke; results from 9 years of follow-up in a population based cohort of Iran
    Noushin Fahimfar, Davood Khalili, Reza Mohebi, Fereidoun Azizi, Farzad Hadaegh · 2012 · BMC Neurology
35. Metabolic Memory for Vascular Disease in Diabetes
    Pablo J. Aschner, Álvaro J. Ruiz · 2012 · Diabetes Technology & Therapeutics
36. Quality of Diabetes Care in Germany Improved from 2000 to 2007 to 2014, but Improvements Diminished since 2007. Evidence from the Population-Based KORA Studies
    Michael Laxy, Gabriella Knoll, Michaela V. Schunk, Christa Meisinger, Cornelia Huth, Rolf Holle · 2016 · PLoS ONE
37. The importance of glycated haemoglobin (HbA1c) and postprandial glucose (PPG) control on cardiovascular outcomes in patients with type 2 diabetes
    Pan Chang Yu, Zsolt Bosnyák, Antonio Ceriello · 2010 · Diabetes Research and Clinical Practice
38. Diabetes Diagnosis and Control: Missed Opportunities to Improve Health
    Catherine C. Cowie · 2019 · Diabetes Care
39. Mediation of the effect of glycemia on the risk of CVD outcomes in type 1 diabetes: the DCCT/EDIC study
    Bebu, Ionut, Braffett, Barbara H., Orchard, Trevor J., Lorenzi, Gayle M., Lachin, John M., the DCCT/EDIC Research Group · 2019 · Diabetes Care
40. Long-Term Glycemic Control Influences the Long-Lasting Effect of Hyperglycemia on Endothelial Function in Type 1 Diabetes
    Antonio Ceriello, Katherine Esposito, Michael A. Ihnat, Jessica E. Thorpe, Dario Giugliano · 2009 · The Journal of Clinical Endocrinology & Metabolism
41. Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control
    S. Akalin, Kerstin E. Berntorp, Antonio Ceriello, A. K. Das, Eric S. Kilpatrick, Teresa Koblik, C. Munichoodappa, Changyu Pan, W. Rosenthall, Marina Vladimirovna Shestakova et al. · 2009 · International Journal of Clinical Practice
42. Predictive factors of diabetic complications: a possible link between family history of diabetes and diabetic retinopathy
    Zhila Maghbooli, Parvin Pasalar, Abbasali Keshtkar, Farshad Farzadfar, Bagher A. Larijani · 2014 · Journal of Diabetes & Metabolic Disorders
43. Mobile Telemonitoring for Achieving Tighter Targets of Blood Pressure Control in Patients with Complicated Diabetes: A Pilot Study
    Earle, Kenneth A., Istepanian, Robert S.H., Zitouni, Karima, Sungoor, Ala, Tang, Bee · 2010 · Diabetes Technology & Therapeutics
44. Current challenges in the clinical management of hypertension
    Luis Miguel Ruilope · 2011 · Nature Reviews Cardiology
45. Clinical Application of Incretin-Based Therapy: Therapeutic Potential, Patient Selection and Clinical Use
    David M. Kendall, Robert M Cuddihy, Richard M. Bergenstal · 2009 · European Journal of Internal Medicine
46. Non-Coding RNA and Diabetic Kidney Disease
    Huiwen Ren, Qiuyue Wang · 2021 · DNA and Cell Biology
47. The Diabetes Control and Complications Trial: the gift that keeps giving
    Eric S. Kilpatrick, Alan S. Rigby, Stephen Lawrence Atkin · 2009 · Nature Reviews Endocrinology
48. Adding liraglutide to oral antidiabetic drug therapy: onset of treatment effects over time
    Baptist Gallwitz, Allan Arthur Vaag, Ali Falahati, Sten Madsbad · 2009 · International Journal of Clinical Practice
49. Benefits of moderate weight loss in patients with type 2 diabetes
    Ken Fujioka · 2009 · Diabetes Obesity and Metabolism
50. HIF-1α accumulation in response to transient hypoglycemia may worsen diabetic eye disease
    Chuanyu Guo, Monika M. Deshpande, Yueqi Niu, Isha A. Kachwala, Miguel Flores‐Bellver, Haley Megarity, Taylor Nuse, Savalan Babapoor-Farrokhran, Michael Ramada, Jaron Castillo Sanchez et al. · 2023 · Cell Reports
51. Evidence That Multiple Defects in Lipid Regulation Occur before Hyperglycemia during the Prodrome of Type-2 Diabetes
    Simon George Anderson, Warwick B. Dunn, Moulinath Banerjee, Marie Brown, David Broadhurst, Royston Goodacre, Garth J. S. Cooper, Douglas Bruce Kell, John Kennedy Cruickshank · 2014 · PLoS ONE
52. Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial
    Griffin, Simon J, Rutten, Guy E H M, Khunti, Kamlesh, Witte, Daniel R, Lauritzen, Torsten, Sharp, Stephen J, Dalsgaard, Else-Marie, Davies, Melanie J, Irving, Greg J, Vos, Rimke C et al. · 2019 · The Lancet Diabetes & Endocrinology
53. A Survey of the Management, Control, and Complications of Diabetes Mellitus in Patients Attending a Diabetes Clinic in Blantyre, Malawi, an Area of High HIV Prevalence
    Danielle B. Cohen, Theresa J. Allain, Simon J. Glover, Daniel Chimbayo, Helen Dzamalala, Helma W. C. Hofland, Ndaziona Peter Kwanjo Banda, EE Zijlstra · 2010 · American Journal of Tropical Medicine and Hygiene
54. Social Network Characteristics Are Associated With Type 2 Diabetes Complications: The Maastricht Study
    Stephanie Brinkhues, Nicole H. T. M. Dukers–Muijrers, Christian J. P. A. Hoebe, Carla Kallen, Annemarie Koster, Ronald M.A. Henry, Coen D.A. Stehouwer, Paul H. M. Savelkoul, Nicolaas C. Schaper, Miranda T. Schram · 2018 · Diabetes Care
55. From design to implementation - The Joint Asia Diabetes Evaluation (JADE) program: A descriptive report of an electronic web-based diabetes management program
    Gary T.C. Ko, Wing‐Yee So, Peter C.Y. Tong, Francois Le Coguiec, Debborah Kerr, Greg Lyubomirsky, B V Tamesis, Troels Wolthers, Jennifer H. Nan, Juliana C.N. Chan · 2010 · BMC Medical Informatics and Decision Making
56. Effects of glucagon‐like peptide‐1 receptor agonists on cardiovascular risk factors: A narrative review of head‐to‐head comparisons
    Niels B. Dalsgaard, Tina Vilsbøll, Filip Krag Knop · 2017 · Diabetes Obesity and Metabolism
57. Efficacy and Safety of Incretin-Based Therapies in Patients with Type 2 Diabetes Mellitus
    Matthew Philip Gilbert, Richard E. Pratley · 2009 · The American Journal of Medicine
58. Predictive power of home blood pressure and clinic blood pressure in hypertensive patients with impaired glucose metabolism and diabetes
    Yuichi Noguchi, Kei Asayama, Jan Albert Staessen, Munemichi Inaba, Takayoshi Ohkubo, Miki Hosaka, Michihiro Satoh, Kei Kamide, Takuya Awata, Shigehiro Katayama et al. · 2013 · Journal of Hypertension
59. Diabetes and Cardiovascular Disease Prevention in Older Adults
    Cigolle, Christine T., Blaum, Caroline S., Halter, Jeffrey B. · 2009 · Clinics in Geriatric Medicine
60. Banting Memorial Lecture 2010∧. Type 2 diabetes as an ‘infectious’ disease: is this the Black Death of the 21st century?
    David Richard Matthews, Philippa Clare Matthews · 2010 · Diabetic Medicine
61. Healthcare utilization of people with Type 2 diabetes in Germany: an analysis based on health insurance data
    Nicolle Muller, Tabitha Heller, M. Freitag, Bettina Gerste, Christiane M. Haupt, Günter Wolf, Ulrich Müller · 2015 · Diabetic Medicine
62. Hypertension Management and Microvascular Insulin Resistance in Diabetes
    Seung‐Hyun Ko, Wenhong Cao, Zhenqi Liu · 2010 · Current Hypertension Reports
63. Hyperglycaemia and the vessel wall: the pathophysiological aspects on the atherosclerotic burden in patients with diabetes
    Antonio Ceriello · 2010 · European Journal of Cardiovascular Prevention & Rehabilitation
64. Hypertension in diabetes and the risk of cardiovascular disease
    Nirmal T. Sunkara, Chowdhury H. Ahsan · 2017 · Cardiovascular Endocrinology
65. Use of Glycated Hemoglobin in the Diagnosis of Diabetes Mellitus and Pre-diabetes and Role of Fasting Plasma Glucose, Oral Glucose Tolerance Test.
    Naser Alqahtani, Waseem Abdul Ghafor Khan, Mohamed Husain Alhumaidi, Yasar Ahmed · 2013 · Europe PMC (PubMed Central)
66. Prevention and Treatment of Diabetic Retinopathy: Evidence from Clinical Trials and Perspectives
    Manuela Abbate, Paolo Cravedi, Ilian Petrov Iliev, Giuseppe Remuzzi, Piero Luigi Ruggenenti · 2011 · Current Diabetes Reviews
67. Pay for perfomance and the quality of diabetes management in individuals with and without co-morbid medical conditions
    Christopher J. Millett, Alex Bottle, Anthea Ng, Vasa Ćurčin, Mariam Molokhia, Sonia K Saxena, Azeem Majeed · 2009 · Journal of the Royal Society of Medicine
68. Qualitative study of telemonitoring of blood glucose and blood pressure in type 2 diabetes
    Hanley, Janet, Fairbrother, Peter, McCloughan, Lucy, Pagliari, Claudia, Paterson, Mary, Pinnock, Hilary, Sheikh, Aziz, Wild, Sarah, McKinstry, Brian · 2015 · BMJ Open
69. Intensive Blood Pressure Control Affects Cerebral Blood Flow in Type 2 Diabetes Mellitus Patients
    Yu-Sok Kim, Shyrin C.A.T. Davis, Jasper Truijen, Wim J. Stok, Niels Henry Secher, Johannes J. VAN LIESHOUT · 2011 · Hypertension
70. The goal of blood pressure in the hypertensive patient with diabetes is defined: now the challenge is go from recommendations to practice
    Patricio A López-Jaramillo, José López-López, Cristina Lopez-Lopez, Miguel I Rodriguez-Alvarez · 2014 · Diabetology & Metabolic Syndrome
71. The Role of Beta-Blockers in the Treatment of Hypertension
    John Malcolm Cruickshank · 2016 · Advances in experimental medicine and biology
72. Poor Glycaemic Control Is Associated with Increased Lipid Peroxidation and Glutathione Peroxidase Activity in Type 2 Diabetes Patients
    Harshi Prasadini Gunawardena, Renuka Silva, R. Sivakanesan, Pathmasiri Ranasinghe, Prasad Katulanda · 2019 · Oxidative Medicine and Cellular Longevity
73. Targeted antioxidant therapies in hyperglycemia-mediated endothelial dysfunction
    Judy B. de Haan · 2010 · Frontiers in Bioscience-Scholar
74. Structured personal care of type 2 diabetes: a 19 year follow-up of the study Diabetes Care in General Practice (DCGP)
    Lars J. Hansen, Volkert Siersma, Henning Beck‐Nielsen, Niels de Fine Olivarius · 2013 · Diabetologia
75. Medicare Spending for Previously Uninsured Adults
    J. Michael McWilliams, Ellen Meara, Alan M. Zaslavsky, John Z. Ayanian · 2009 · Annals of Internal Medicine
76. Oxytocin: Potential to mitigate cardiovascular risk
    Allison Bethanne Reiss, Daniel S. Glass, Eric Lam, Amy D. Glass, Joshua De Leon, Lora J. Kasselman · 2019 · Peptides
77. Do the SGLT-2 Inhibitors Offer More than Hypoglycemic Activity?
    Eduardo Flores, Carlos G. Santos‐Gallego, Nely Mercy Diaz Mejia, Juan J. Badimón · 2018 · Cardiovascular Drugs and Therapy
78. Mortality and Morbidity During and After the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial
    William C. Cushman, Barry R. Davis, Sara Pressel, Jeffrey A. Cutler, Paula T. Einhorn, Charles E. Ford, Suzanne Oparil, Jeffrey L. Probstfield, Paul Kieran Whelton, Jackson T. Wright et al. · 2011 · Journal of Clinical Hypertension
79. Association of processes of primary care and hospitalisation for people with diabetes: A record linkage study
    Elizabeth Jean Comino, Md Fakhrul Islam, Duong Thuy Tran, Louisa R. Jorm, Jeff R. Flack, Bin Badrudin Jalaludin, Marion R. Haas, Mark Harris · 2015 · Diabetes Research and Clinical Practice
80. Cardiovascular Protective Effect of Metformin and Telmisartan: Reduction of PARP1 Activity via the AMPK-PARP1 Cascade
    Fenqing Shang, Jiao Zhang, Zhao Li, Jin Zhang, Yanjun Yin, Yaqiong Wang, Traci Marin, Brendan Gongol, Han Xiao, Youyi Zhang et al. · 2016 · PLoS ONE
81. Persistence of Mortality Reduction After the End of Randomized Therapy in Clinical Trials of Blood Pressure–Lowering Medications
    William J. Kostis, Lutgarde Thijs, Tom Richart, John B. Kostis, Jan A. Staessen · 2010 · Hypertension
82. Cost-effectiveness of saxagliptin (Onglyza®) in type 2 diabetes in Sweden
    Ola Granström, Klas Bergenheim, Phil C. McEwan, Karin Sennfält, Martin Henriksson · 2011 · Primary care diabetes
83. Changing the Treatment Paradigm for Type 2 Diabetes
    Stefano Del Prato, Giuseppe Penno, Roberto Miccoli · 2009 · Diabetes Care
84. Glycemic Exposure, Glycemic Control, and Metabolic Karma in Diabetic Complications
    Merlin C. Thomas · 2014 · Advances in Chronic Kidney Disease
85. The effect of exercise training on ankle-brachial index in type 2 diabetes
    Bethany Barone Gibbs, Devon A. Dobrosielski, Andrew D. Althouse, Kerry J. Stewart · 2013 · Atherosclerosis
86. Do the Benefits of Participation in a Hypertension Self-Management Trial Persist After Patients Resume Usual Care?
    Matthew L. Maciejewski, Hayden Barry Bosworth, Maren K. Olsen, Valerie A. Smith, David E. Edelman, Benjamin J. Powers, Miriam A. Kaufman, Eugene Ž. Oddone, George L. Jackson · 2014 · Circulation Cardiovascular Quality and Outcomes
87. Benefits of Tight Blood Pressure Control in Diabetic Patients With Hypertension
    Gianfranco Parati, Grzegorz Bilo, Juan Eugenio Ochoa · 2011 · Diabetes Care
88. SGLT2 inhibitors: glucuretic treatment for type 2 diabetes
    Clifford J. Bailey, Caroline Day · 2010 · The British Journal of Diabetes
89. Impact of CKD Progression on Cardiovascular Disease Risk in a Contemporary UK Cohort of Individuals With Diabetes
    Claudia S. Cabrera, Alison S. Lee, Marita Olsson, Volker Schnecke, Klara Westman, Marcus Lind, Peter J. Greasley, Stanko Skrtic · 2020 · Kidney International Reports
90. Balancing Risk and Benefit with Oral Hypoglycemic Drugs
    Ole‐Petter R. Hamnvik, Graham T. McMahon · 2009 · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine
91. Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies
    Matthias Meier · 2009 · Vascular Health and Risk Management
92. Implications of Recently Published Trials of Blood Pressure–Lowering Drugs in Hypertensive or High-Risk Patients
    Jan Albert Staessen, Tom Richart, Zengwu Wang, Lutgarde Thijs · 2010 · Hypertension
93. The many faces of diabetes. Is there a need for re-classification? A narrative review
    Nasser Sakran, Yitka N. H. Graham, Tadeja Pintar, Wah Yang, Radwan Kassir, E.M. Willigendael, Rishi Singhal, Zoë E. Kooreman, Dharmanand Ramnarain, Kamal Kumar Mahawar et al. · 2022 · BMC Endocrine Disorders
94. Efficacy and Safety of Incretin-Based Therapies in Patients with Type 2 Diabetes Mellitus
    Matthew Philip Gilbert, Richard E. Pratley · 2009 · European Journal of Internal Medicine
95. Cardiovascular Outcomes in Framingham Participants With Diabetes: The Importance of Blood Pressure
    W.J. Elliott · 2012 · Yearbook of Cardiology
96. Renal glucose handling in diabetes and sodium glucose cotransporter 2 inhibition
    ReshamRaj Poudel · 2013 · Indian Journal of Endocrinology and Metabolism
97. Understanding the inter‐relationship between improved glycaemic control, hypoglycaemia and weight change within a long‐term economic model
    P McEwan, Marc Evans, H. Kan, Klas Bergenheim · 2009 · Diabetes Obesity and Metabolism
98. Management of type 2 diabetes mellitus in the elderly
    Kyaw Khaing Soe, Alan Scott Sacerdote, J Karam, Gül Bahtiyar · 2011 · Maturitas
99. Hypertension is the Prominent Risk Factor in Cataract Patients
    Ioanna Mylona, Maria Dermenoudi, Nikolaos G. Ziakas, Ioannis Tsinopoulos · 2019 · Medicina
100. Metabolic memory: Evolving concepts
     Anoop Misra, Zachary T. Bloomgarden · 2017 · Journal of Diabetes